The FOUNDATION Study: Hospital Formulation Of B. infantis EVC001 Utilized In The NICU To Demonstrate Tolerability In Our Preterm Neonates

The proposed clinical study will evaluate the tolerability of feeding preterm infants a B. infantis probiotic (EVC001) as the primary endpoint. This particular strain of Bifidobacterium has been shown to uniquely utilize oligosaccharides found in human breast milk, possibly providing a nutritional benefit for the infant consuming breast milk when B. infantis is colonized in the gut.

本项拟开展的临床研究将以给早产婴儿喂食婴儿双歧杆菌（B. infantis）EVC001益生菌的耐受性作为主要终点指标进行评估。该株双歧杆菌已被证实可特异性利用人母乳中的低聚糖，当婴儿肠道定植婴儿双歧杆菌时，可能为摄入母乳的婴儿带来营养益处。